Someone talk to me about this fraud that occurred in the mishandling of data. It seems the company has been pretty tight lipped.
Did these 4 employees manipulate the data to make it seem their tests worked? Or was it just something else? If it was something else and the technology works I think we are looking at a bargain here at $3.00.
I mean this was just a $15 stock. I'm thinking of taking a small position here with the possibility of a 2 bagger quite possible.
I just can not find out enough information on what happened. I think if the company comes out and says the tampering was not that bad the stock surges. Problem is, how much downside do we have?
0
To remove first post, remove entire topic.
Someone talk to me about this fraud that occurred in the mishandling of data. It seems the company has been pretty tight lipped.
Did these 4 employees manipulate the data to make it seem their tests worked? Or was it just something else? If it was something else and the technology works I think we are looking at a bargain here at $3.00.
I mean this was just a $15 stock. I'm thinking of taking a small position here with the possibility of a 2 bagger quite possible.
I just can not find out enough information on what happened. I think if the company comes out and says the tampering was not that bad the stock surges. Problem is, how much downside do we have?
The issues are going to be if even the FDA accepts the data and what hoops they make SQNM jump through since this is an issue of confidence too. This situation makes the FDA look stupid and they might not work with SQNM.
Now if the issue is temporary and insignificant and the data is easy to repair, then the stock is a 5 bagger and quick.
0
Ive thought the same things.
The issues are going to be if even the FDA accepts the data and what hoops they make SQNM jump through since this is an issue of confidence too. This situation makes the FDA look stupid and they might not work with SQNM.
Now if the issue is temporary and insignificant and the data is easy to repair, then the stock is a 5 bagger and quick.
My understanding is that FDA approval is not required. It's more a matter of adoption by the medical establishment. They are looking to do a largest test to be published in a large peer reviewed journal.
The downside is $0. They have all their eggs in this basket. If it goes down in flames the company is over. This is one of those stocks that in 2 years time or sooner will be either $0 or $25+. Pretty good risk/reward.
0
My understanding is that FDA approval is not required. It's more a matter of adoption by the medical establishment. They are looking to do a largest test to be published in a large peer reviewed journal.
The downside is $0. They have all their eggs in this basket. If it goes down in flames the company is over. This is one of those stocks that in 2 years time or sooner will be either $0 or $25+. Pretty good risk/reward.
If you choose to make use of any information on this website including online sports betting services from any websites that may be featured on
this website, we strongly recommend that you carefully check your local laws before doing so.It is your sole responsibility to understand your local laws and observe them strictly.Covers does not provide
any advice or guidance as to the legality of online sports betting or other online gambling activities within your jurisdiction and you are responsible for complying with laws that are applicable to you in
your relevant locality.Covers disclaims all liability associated with your use of this website and use of any information contained on it.As a condition of using this website, you agree to hold the owner
of this website harmless from any claims arising from your use of any services on any third party website that may be featured by Covers.